In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  18F-fluoromisonidazole
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: TMH-IRB 843, NCT01391065

2.

Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: HNO-FMISO-FU, NCT00180180

3.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UW-6143, UW IRB# 6143, 7958, NCT00559377

4.

Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-151, NCT00574353

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01912, CDR0000640413, U01CA080098, ACRIN 6684, NCT00902577

6.

Phase: Phase II
Type: Health services research
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX2008/31, NCT00906893

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UW-8468, 6971, 8468, NCT01169350

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ENT0025, 98781, SU-03052009-1958, SUMC-ENT 0025, 8209, NCT00841997, NCT00896181

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2009-015543-16, NCT01200134

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-1106, RTOG-1106/ACRIN-6697, NCT01507428

11.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 0932103, NCT01619696

12.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 100, NCT00159978

13.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 04-070, NCT00606294

14.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VAR0032, NCT01123005

15.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX 2008/20, NCT01235052

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: UCL-TUMOR-ANGIOGENESIS, UCL-Tumour Angiogenesis, EU-21086, NCT01254591

17.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI44704, NCT01246869

18.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GI 1026, NCT01330186

19.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-174, NCT01613521

20.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HIL-DOT-MOBI, NCT01617980
New Search